The future of animal models of invasive aspergillosis.
暂无分享,去创建一个
[1] W. M. Foster,et al. Value of an inhalational model of invasive aspergillosis. , 2004, Medical mycology.
[2] S. Balajee,et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. , 2004, The Journal of infectious diseases.
[3] E. Estey,et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome , 2004 .
[4] S. Filler,et al. Novel Inhalational Murine Model of Invasive Pulmonary Aspergillosis , 2004, Antimicrobial Agents and Chemotherapy.
[5] Steve A. Hernandez,et al. Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories , 2004, Antimicrobial Agents and Chemotherapy.
[6] R. Soiffer,et al. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. , 2003, Blood.
[7] T. Walsh,et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. , 2003, The Journal of infectious diseases.
[8] D. Denning,et al. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. , 2003, Journal of Antimicrobial Chemotherapy.
[9] J. Perfect,et al. Newer antifungal therapy for emerging fungal pathogens. , 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[10] T. Patterson,et al. Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis , 2002, Antimicrobial Agents and Chemotherapy.
[11] H. Einsele,et al. Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis. , 2002, The Journal of infectious diseases.
[12] A. Francesconi,et al. Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia , 2002, Antimicrobial Agents and Chemotherapy.
[13] D. Schmatz,et al. Quantitative PCR Assay To MeasureAspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate , 2001, Antimicrobial Agents and Chemotherapy.
[14] D. McMurray,et al. Disease model: pulmonary tuberculosis. , 2001, Trends in molecular medicine.
[15] J. Graybill. The role of murine models in the development of antifungal therapy for systemic mycoses. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[16] M. Rinaldi,et al. Efficacy of Voriconazole in a Guinea Pig Model of Disseminated Invasive Aspergillosis , 2000, Antimicrobial Agents and Chemotherapy.
[17] William R. Kirkpatrick,et al. Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.
[18] W. Leisenring,et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.
[19] T. Patterson,et al. Aspergillus antigen detection in the diagnosis of invasive aspergillosis. , 1995, The Journal of infectious diseases.
[20] A. Francesconi,et al. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy , 1995, Antimicrobial agents and chemotherapy.
[21] T. Walsh,et al. Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis , 1994, Antimicrobial Agents and Chemotherapy.
[22] M. Rinaldi,et al. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis , 1993, Antimicrobial Agents and Chemotherapy.
[23] T. Patterson,et al. Saperconazole therapy in a rabbit model of invasive aspergillosis , 1992, Antimicrobial Agents and Chemotherapy.
[24] T. Patterson,et al. Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] T. Patterson,et al. Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis , 1991, Antimicrobial Agents and Chemotherapy.
[26] T. Walsh,et al. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice , 1989, Infection and immunity.
[27] F. Szoka,et al. Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. , 1989, The Journal of infectious diseases.
[28] J. Ryan,et al. Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model. , 1988, The Journal of infectious diseases.
[29] V. Andriole,et al. The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. , 1985, The Journal of infectious diseases.
[30] J. Graybill,et al. Treatment of experimental murine aspergillosis with BAY n7133. , 1983, The Journal of infectious diseases.